PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24524041-10	2012	RESULTS: alphaTP-suc inhibits osteoclast formation in cocultures stimulated by IL-1 and decreased the level of expression of RANKL mRNA in osteoblasts.	alpha-Tocopherol	9-20	interleukin 1 complex	Mus musculus	79-83	
24524041-11	2012	In addition, administered intraperitoneal injections of alphaTP-suc prevented IL-1-mediated osteoclast formation and bone loss in vivo.	alpha-Tocopherol	56-67	interleukin 1 complex	Mus musculus	78-82	
8108271-0	1993	Effects of RRR-alpha-tocopheryl succinate on IL-1 and PGE2 production by macrophages.	alpha-Tocopherol	15-41	interleukin 1 complex	Mus musculus	45-49	
8108271-2	1993	In an effort to understand the mechanism(s) whereby the form of vitamin E known as RRR-alpha-tocopheryl succinate [also called vitamin E succinate (VES)] ameliorates retrovirus-induced immune dysfunctions, peritoneal exudate cells (PECs) derived from normal chickens and avian and murine macrophage cell lines were used as in vitro model systems to test the effects of VES treatments on PGE2 and IL-1 production.	alpha-Tocopherol	87-113	interleukin 1 complex	Mus musculus	396-400	
8108271-2	1993	In an effort to understand the mechanism(s) whereby the form of vitamin E known as RRR-alpha-tocopheryl succinate [also called vitamin E succinate (VES)] ameliorates retrovirus-induced immune dysfunctions, peritoneal exudate cells (PECs) derived from normal chickens and avian and murine macrophage cell lines were used as in vitro model systems to test the effects of VES treatments on PGE2 and IL-1 production.	alpha-Tocopherol	127-146	interleukin 1 complex	Mus musculus	396-400	
8108271-2	1993	In an effort to understand the mechanism(s) whereby the form of vitamin E known as RRR-alpha-tocopheryl succinate [also called vitamin E succinate (VES)] ameliorates retrovirus-induced immune dysfunctions, peritoneal exudate cells (PECs) derived from normal chickens and avian and murine macrophage cell lines were used as in vitro model systems to test the effects of VES treatments on PGE2 and IL-1 production.	alpha-Tocopherol	148-151	interleukin 1 complex	Mus musculus	396-400